ABSTRACT The objective of this study consisting of 2 trials was to investigate the antioxidant role of conjugated linoleic acid (CLA) isomers (c9, t11-CLA and t10, c12-CLA) and the underlying mechanism by which they act in modulating redox status in a primary laying hen hepatocyte culture. In trial 1, the cytotoxicity of CLA isomers or linoleic acid (LA) (0, 25, 50, 100, 200, 400, 800 μmol/L) was evaluated by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The concentration of CLA isomers or LA (25, 50, 100 μmol/L) for proper antioxidant activity was evaluated by measuring the antioxidant enzyme activity. In trial 2, there were 5 groups: control group, cells were untreated; H 2 O 2 group, cells were exposed to 4 mmol/L H 2 O 2 for 2 h; c9, t11 or t10, c12 or LA group, cells were treated with c9, t11-CLA or t10, c12-CLA or LA for 24 h and then exposed to 4 mmol/L H 2 O 2 for 2 h. Trial 1 showed that the non-toxic dose range for CLA isomers was 0 to 200 μmol/L. The optimum concentration of c9, t11-CLA and t10, c12-CLA for trial 2 was 100 μmol/L. In trial 2, pretreatment with t10, c12-CLA but not c9, t11-CLA attenuated the increase in reactive oxygen species (ROS) compared to hydrogen peroxide (H 2 O 2 ) group (P < 0.05). t10, c12-CLA elevated the superoxide dismutase (SOD) and catalase (CAT) activities compared with the H 2 O 2 group (P < 0.05). In addition, t10, c12-CLA up-regulated the mRNA expression of nuclear factor E2-related factor-2 (Nrf2) as well as its target genes, Cu-Zn superoxide dismutase (SOD1) and CAT (P < 0.05). Pretreatment with t10, c12-CLA but not c9, t11-CLA decreased Nrf2 protein expression in the cytoplasm and increased Nrf2 protein expression in the nucleus compared with the H 2 O 2 group (P < 0.05). The results indicate that t10, c12-CLA exhibits a stronger antioxidant capacity than c9, t11-CLA in primary cultured laying hen hepatocytes. t10, c12-CLA increases the activity and mRNA expression of antioxidant enzymes via facilitating nuclear translocation of Nrf2.
INTRODUCTION
Oxidative stress, which is induced by an imbalance between reactive oxygen species (ROS) and antioxidants, causes a wide variety of diseases, including atherosclerosis, diabetes, pulmonary fibrosis, and neurodegenerative disorders (Bergamo et al., 2013 ). Antioxidant enzymes, such as superoxide dismutase (SOD) and catalase (CAT), are part of the defense system and play a critical role in protecting the cells against oxidative damage by H 2 O 2 (Xing and Jian, 2011 (GHQ) and CAT reduces H 2 O 2 to H 2 O (Xi et al., 2010) . H 2 O 2 is an endogenous source of hydroxyl free radicals that contributes to the background level of cellular oxidative stress (Halliwell, 1992) . Exogenous H 2 O 2 can elevate oxidative stress beyond the protective capacity of endogenous antioxidant defenses (Maroto and Perez-Polo 1997) . Therefore, H 2 O 2 is widely used as an inducer of oxidative stress in in vitro cell culture assays (Li et al., 2010) .
Nrf2 plays an important role in ARE-mediated antioxidant gene expression (Jaiswal, 2004) . Normally, Nrf2 is bound to Kelch-like ECH-associated protein-1 (Keap1) and sequestered in the cytoplasm. When challenged by oxidative stress or other stimulating factors, Nrf2 is released from Keap1 and rapidly translocates into the nucleus, which leads to transcriptional activation of antioxidant genes (Ishii et al., 2000; Li and Kong, 2009 ), such as SOD and CAT.
Conjugated linoleic acid (CLA) is a mixture of positional and geometric linoleic acid isomers and mainly includes 2 isomers: c9, t11-CLA and t10, c12-CLA. Conjugated linoleic acid has many beneficial properties, one of which is that it is a potent anticarcinogen in various models (Ha et al., 1990; Ip et al., 1994) , and its antioxidant activity may be the basis for its anticarcinogenic effect (Pariza et al., 1991) . However, whether CLA is an antioxidant remains controversial. Certain studies indicate that CLA acts as an antioxidant (Bergamo et al., 2007 (Bergamo et al., , 2011 Chinnadurai et al., 2013; Basiricò et al., 2017; Huang et al., 2018) . In contrast, other researches show that CLA does not display a clear antioxidant effect; it may even be a pro-oxidant (Nakamura and Omaye, 2009; Rybicka et al., 2011; Hanschke et al., 2016) . In a previous study, we investigated the effects of dietary CLA on antioxidant capacity in laying hens. The results showed that CLA supplementation significantly increased the activities of antioxidant enzymes, inhibited ROS production, and decreased malondialdehyde (MDA) concentrations (Qi et al., 2011) . Additionally, individual CLA isomers differ in their antioxidant actions. Based on the total oxyradical scavenging capacity, t10, c12-CLA acted as an antioxidant at a range of 2 to 200 μmol/L; c9, t11-CLA possessed weak antioxidant activity only at 2 and 20 μmol/L, but acted as a strong pro-oxidant at 200 μmol/L (Leung and Liu, 2000) . In contrast, dietary supplementation with c9, t11-CLA in young rats activated Nrf2-mediated cytoprotective defenses against oxidative stress more efficiently than t10, c12-CLA (Mollica et al., 2014) . Taken together, the differences of animal models (rat, cell line, chicken, cow, fish), measurements (enzyme system, nonenzyme system), duration, CLA source and concentration are the main reasons for the inconsistent results. Moreover, CLAs have not only antioxidant property but also other functions. Therefore, it is necessary to specifically study the antioxidant capacity of different CLAs.
Although much attention has been given on the antioxidant activity of CLA, little is known about the actions of specific isomers on CLA-mediated enhancement of antioxidant enzyme activity. This study was undertaken for the first time to assess the antioxidant potential of 2 major CLA isomers (c9, t11-CLA and t10, c12-CLA) in a primary chicken hepatocyte culture. The purpose of our investigation is primarily to study (i) whether both CLA isomers act as an antioxidant; (ii) which CLA isomer plays a main role in the oxidoreduction equilibrium; and (iii) the mechanisms underlying CLA isomer(s) modulation of the primary hepatocytes' antioxidant capacity.
MATERIALS AND METHODS

Reagents
The following products from Sigma-Aldrich (St. Louis, MO) were used: penicillin (P3032), streptomycin (S9137), hydrogen peroxide (323381), insulin (I9278), Nitrotetrazolium Blue chloride (N6876), and Thiazolyl Blue Tetrazolium Bromide (M2128). The following products from Gibco, Invitrogen (USA) were used: William's E medium (12, , fetal bovine serum (FBS) (10,099-141), L-Glutamine (25030081) and collagenase type IV (17, . c9, t11-CLA (1245) and t10, c12-CLA (1249) were obtained from Matreya, LLC (purity, > 98%). Linoleic acid (LA, purity, ≥ 99%, L2376) was obtained from Sigma-Aldrich (St. Louis, MO).
Laying Hen Primary Hepatocyte Culture
Hepatocytes were obtained from Hy-Line Brown laying hens. The experimental use of animals was approved by the Animal Care and Use Committee of the Feed Research Institute of the Chinese Academy of Agricultural Sciences. The hepatocytes were isolated using the collagenase perfusion method in situ as described previously (Zhou et al., 2012) , with modifications. Briefly, the laying hen was fasted overnight before surgery. Next, we injected heparin sodium and pentobarbital sodium for blood anticoagulant and anesthesia, respectively. The tubal and pancreaticoduodenal veins were ligated before liver perfusion. First, the liver was perfused with sterile perfusate A (1.192 g HEPES, 4.003 g NaCl, 0.112 g KCl, 0.537 g Na 2 HPO 4 ·12H 2 O, and 0.931 g EDTA-Na 2 dissolved in 500 mL of ultrapure water, pH 7.4, 40
• C) via the mesenteric vein until the liver blood was washed away. Second, after cutting off the superior vena cava, the liver was perfused with sterile perfusate B (perfusate A without EDTA-Na 2 , pH 7.4, 40
• C) until the liquid flowing from the liver was clear. Third, sterile perfusate C (perfusate B with collagenase type IV, pH 7.4, 42
• C) was used to digest liver tissue until the liver appeared to crack. Next, the digested liver tissue was transferred to a sterile dish, and the liver capsule was removed. Immediately, 50 mL of serum-free William's E medium supplemented with antibiotics (100 IU/mL penicillin and 100 μg/mL streptomycin) was added to the dish. The cell suspension was filtered once through each mesh (grid size 150, 75, and 38 μm, respectively) and centrifuged at 500 × g for 10 min. The cell pellets were then resuspended and washed twice with the same medium. Finally, the cell pellets were resuspended in William's E medium (plating medium) containing 10% FBS, 10 μg/mL human transferrin, 10 −6 M dexamethasone, 10 −6 M human insulin, 1% antibiotics, and 2 mmol/L L-glutamine. The isolated hepatocyte viability was greater than 95%, which was determined using a Trypan blue exclusion test. Approximately 96% of the isolated cells were hepatocytes, which were evaluated using light microscopy. In this culture system (collagenase perfusion in situ), hepatocytes formed monolayers quickly and recovered the typical polygonal shape within 4 h (Legrand et al., 1997) . The hepatocytes were plated with plating medium and incubated for 4 h at 37
• C in a 5% CO 2 atmosphere. The medium was Figure 1 . Cytotoxicity of c9, t11 and t10, c12-CLA on hepatocytes. Hepatocytes were treated with c9, t11-CLA (0, 25, 50, 100, 200, 400, 800 μmol/L); t10, 25, 50, 100, 200, 400, 800 μmol/L) or LA (0, 25, 50, 100, 200, 400, 800 μmol/L) for 24 h. The cytotoxicity of c9, t11 and t10, c12-CLA or LA on hepatocytes was evaluated by MTT assay. The data for 1 representative experiment from 3 independent experiments are expressed as the mean ± SEM (n = 6).
then replaced with fresh growth medium (William's E medium supplemented with 10% FBS, 1% antibiotics, and 2 mmol/L L-glutamine), and the hepatocytes were incubated for an additional 20 h to generate a monolayer culture.
Cell Treatment
Trial 1 This experiment was conducted to screen the properly functional concentration of CLA isomers for trial 2. Firstly, hepatocytes were treated with c9, t11-CLA (0, 25, 50, 100, 200, 400, 800 μmol/L), t10, 25, 50, 100, 200, 400, 800 μmol/L) or LA (0, 25, 50, 100, 200, 400 , 800 μmol/L) for 24 h. The cytotoxicity of CLA isomers or LA was evaluated by MTT assay (Figure 1 ). Secondly, hepatocytes were pretreated with CLA isomers or LA for 24 h and then exposed to 4 mmol/L H 2 O 2 for 2 h. A 2-h treatment with 4 mmol/L H 2 O 2 was used to induce oxidative stress, which was described in our previous study (Qi et al., 2013) . There were 11 groups: control group, cells were untreated; H 2 O 2 group, cells were exposed to 4 mmol/L H 2 O 2 for 2 h; c9, t11 groups, cells were treated with c9, t11-CLA (25, 50, 100 μmol/L) for 24 h and then exposed to 4 mmol/L H 2 O 2 for 2 h; t10, c12 groups, cells were treated with t10, c12-CLA (25, 50, 100 μmol/L) for 24 h and then exposed to 4 mmol/L H 2 O 2 for 2 h; LA groups, cells were treated with LA (25, 50, 100 μmol/L) for 24 h and then exposed to 4 mmol/L H 2 O 2 for 2 h. The concentration of c9, t11-CLA and t10, c12-CLA for proper antioxidant activity was evaluated by measuring the intracellular SOD and CAT activity ( Figure 2 ).
Trial 2 This experiment was conducted to investigate the antioxidant role of CLA isomers (c9, t11-CLA and t10, c12-CLA) and the underlying mechanism by which they act in modulating redox status. There were 5 groups: the control group, cells were untreated; H 2 O 2 group, cells were exposed to 4 mmol/L H 2 O 2 for 2 h; c9, t11 group, cells were treated with c9, t11-CLA for 24 h and then exposed to 4 mmol/L H 2 O 2 for 2 h; t10, c12 group, cells were treated with t10, c12-CLA for 24 h and then exposed to 4 mmol/L H 2 O 2 for 2 h; LA group, cells were treated with LA for 24 h and then exposed to 4 mmol/L H 2 O 2 for 2 h.
After treatments, hepatocytes were harvested for subsequent analyses. The experiment for cell viability and ROS production assay included 6 replicates per treatment. The experiment for mRNA and activity of antioxidant enzyme, mRNA and protein of Nrf2 and MDA content assay included 3 replicates per treatment. t10, 50, 100 μmol/L) or LA (25, 50, 100 μmol/L) for 24 h. The cultures were then washed twice, and 4 mmol/L H 2 O 2 was added for another 2 h to all cultures except for the control group. The activities of antioxidant enzymes were measured using a spectrophotometric method. The data for 1 representative experiment from 3 independent experiments are expressed as the mean ± SEM (n = 3). Means without a common letter differ (P < 0.05).
Fatty Acid Preparation
Fatty acid stock solutions (c9, t11-CLA; t10, c12-CLA; and LA) were prepared as Eder et al. (2002) described. In brief, the above fatty acids were converted into their sodium salts by adding equimolar quantities of a sodium hydroxide solution. The fatty acid salts were added to the growth medium to generate the final experimental concentration.
Cell Viability
Cell viability was evaluated using the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay as Liu et al. (2009) described with modifications. Briefly, hepatocytes were plated in 96-well plates at a density of 8 × 10 4 cells/well and cultured in an incubator. After a pre-designed treatment, the monolayers were incubated with 0.5 mg/mL MTT in fresh medium at 37
• C for 4 h. The medium containing MTT was removed. Dimethyl sulfoxide (DMSO, 150 μL) was added into each well, and the absorbance at 490 nm was measured using a spectrophotometric microplate reader (Molecular Devices, Silicon Valley, CA).
Intracellular ROS Measurement: Nitroblue Tetrazolium (NBT) Reduction Assay
The intracellular ROS production was quantified as Muñoz et al. (2000) described with modifications. Hepatocytes (8 × 10 4/ well) were plated in 96-well plates. After a pre-designed treatment, the supernatants with H 2 O 2 were removed. Adherent cells were washed with PBS for 3 times. Then, NBT (100 μL of 1 mg/mL) working solution prepared in a fresh medium was added to each well. Following a 2-h incubation, the NBT supernatant was removed and the cells were fixed with methanol. After the wells air-dried, the insoluble blue formazan was dissolved in 2 M KOH (120 μL) and DMSO (140 μL). The absorbance was detected using a spectrophotometer at 620 nm.
Antioxidant Enzymes and Lipid Peroxidation Assay
Hepatocytes were plated in 60-mm dishes at a density of 1 × 10 6 cells/mL. After treatment, the monolayers were washed twice with PBS and harvested. The cell suspension was lysed on ice using a sonicator. The lysates were centrifuged at 12,000 × g for 15 min, and the supernatant was collected for a subsequent analysis. All assays were performed using commercially available assay kits (Nanjing Jiancheng Bioengineering Institute, Jiangsu, China) following the manufacturer's instructions, and a spectrophotometer was used for detection.
The intracellular SOD activity was measured using xanthine and xanthine oxidase systems. One unit is defined as the quantity of enzyme necessary to exhibit 50% dismutation of the superoxide radical. The SOD activity was expressed as U mg 
SYBR Green Real-Time PCR Assay for Gene Expression
The total RNA was extracted from hepatocytes using the TRIzol reagent (Ambion, USA) according to the manufacturer's protocol. The RNA purity was estimated by determining the A260/A280 ratio and then visually confirmed through examining the 18S and 28S bands in a 1% agarose gel stained with ethidium bromide. The total RNA concentration was measured using a spectrophotometer at 260 nm. We reverse transcribed 1 mg RNA using the FastQuant RT Kit (Tangent Biotech (Beijing) Co., Ltd.) following the manufacturer's instructions. The gDNase in this kit is specifically used to remove contaminating DNA from RNA preparations. The gene expression levels were determined using the CFX96 real-time PCR detection system (Bio-Rad Laboratories, Hercules, CA) and superReal Premix Plus (SYBR Green, Tangent Biotech (Beijing) Co., Ltd.). The primers of the selected genes are listed in Table 1 . The real-time PCR reactions were performed using a programmable thermal cycler (denaturation at 95
• C for 15 min followed by 40 cycles of denaturation at 95
• C for 10 s, annealing at 60 • C for 20 s, and extension at 72
• C for 20 s followed by a final extension at 72
• C for 5 min). Each sample was measured in triplicate. All primer concentrations were optimized prior to the experiment. The relative gene expression levels were normalized to the endogenous RNA control β-actin using the 2 −ΔΔCt method (Livak and Schmittgen, 2001 ).
Western Blot Analysis
After treatment, the hepatocytes were washed twice with cold PBS and harvested for Western blotting. The cytosolic and nuclear hepatocyte proteins were extracted using NE-PER nuclear and cytoplasmic extraction kits (Pierce Biotechnology, Rockford, IL, USA). The protein concentration of the extracts was determined using the BCA assay (Pierce Biotechnology). The proteins (30 μL) were separated using SDS-PAGE with 10% acrylamide and then transferred onto a polyvinylidene fluoride membrane. The membrane was blocked for 2 h at room temperature with 5% skim milk containing 0.5 mmol/L Tris-HCl (pH 7.5), 150 mmol/L NaCl, and 0.05% Tween-20. The membrane was subsequently incubated with a rabbit anti-Nrf2 antibody (ab31163, 1: 500 dilution; Abcam) for 2 h at room temperature followed by an HRP-conjugated secondary antibody at a 1: 2000 dilution. The chemiluminescent signal was detected using X-ray film. Protein bands were quantified by densitometric analysis using Image J analysis software (National Institutes of Health, Bethesda, MD).
Statistical Analysis
All data were analyzed using SPSS 19.0 (SPSS Inc., Chicago, IL) and plotted using Origin 8.5 (OriginLab Corp., Northampton, MA). A one-way ANOVA followed by Duncan's multiple comparison test were used to separate the different means among the treatments. The data were assumed statistically significant when P ≤ 0.05. The results are expressed as the mean ± SEM for at least 3 replicates.
RESULTS
Trial 1
After 24-h incubation with CLA isomers, the cell viability decreased significantly (P < 0.05) when the treatment concentration was higher than 200 μmol/L. The result suggested that the non-toxic dose range for CLA isomers was 0 to 200 μmol/L (Figure 1 ). The activities of SOD and CAT increased gradually with the increasing of CLA isomers addition (from 25 to 100 μmol/L). As the concentration of c9, t11-CLA or t10, c12-CLA was increased to 100 μmol/L respectively, the antioxidant capacity of both isomers reached a maximum. Thus, 100 μmol/L for c9, t11-CLA and t10, c12-CLA was used in the study of trial 2 (Figure 2) .
Trial 2
As shown in Figure 3 , a 2 h treatment with 4 mmol/L H 2 O 2 greatly decreased (P < 0.05) cell viability compared with the control group. When the hepatocytes were pretreated with 100 μmol/L c9, t11-CLA or t10, Figure 3 . The effect of c9, t11 and t10, c12-CLA on hepatocyte survival. The effect of c9, t11 and t10, c12-CLA on hepatocyte survival was measured using the MTT assay. Hepatocytes were treated with 100 μmol/L c9, t11-CLA; t10, c12-CLA; or LA for 24 h. The cultures were then washed twice, and 4 mmol/L H 2 O 2 was added for another 2 h to all cultures except for the control group. The data for 1 representative experiment from 3 independent experiments are expressed as the mean ± SEM (n = 6). Means without a common letter differ (P < 0.05). The values for each treatment group are as follows: Control: 100%; H 2 O 2 : 59.16%; c9, t11: 69.10%; t10, c12: 72.89%; LA: 65.75%.
c12-CLA for 24 h, the cellular oxidative damage was significantly reduced (P < 0.05). The cell viability of the t10, c12-CLA group was greater (P < 0.05) than the other groups except for the control and c9, t11-CLA group.
Intracellular ROS production remarkably increased in the hepatocytes exposed to H 2 O 2 (P < 0.05) compared with the control. Pretreatment with t10, c12-CLA markedly attenuated the ROS increase (P < 0.05). Pretreatment with c9, t11-CLA had no effect on ROS level when compared to the H 2 O 2 group (P > 0.05). We did not observe a significant difference (P > 0.05) between the c9, t11-CLA and t10, c12-CLA treatments in preventing the ROS generation (Figure 4) .
The levels of MDA, a biomarker for lipid peroxidation, significantly increased in the H 2 O 2 group compared with the control. Pretreatment with c9, t11-CLA or t10, c12-CLA had no effect (P > 0.05) on MDA content compared with the H 2 O 2 group ( Figure 5) .
Compared with the control, the SOD and CAT activities significantly increased (P < 0.05) after Figure 4 . The effect of c9, t11-CLA and t10, c12-CLA on intracellular ROS production in hepatocytes. Hepatocytes were treated with 100 μmol/L c9, t11-CLA; t10, c12-CLA; or LA for 24 h. The cultures were then washed twice, and 4 mmol/L H 2 O 2 was added for another 2 h to all cultures except for the control group. Intracellular ROS production was evaluated using the NBT reduction assay. The data for 1 representative experiment from 3 independent experiments are expressed as the mean ± SEM (n = 6). Means without a common letter differ (P < 0.05).
exposure to H 2 O 2 for 2 h. Only pretreatment with t10, c12-CLA significantly elevated (P < 0.05) the SOD and CAT activities compared with the H 2 O 2 treatment ( Figure 6 ).
We pretreated hepatocytes with 100 μmol/L t10, c12-CLA for 24 h, which yielded higher SOD1 and CAT mRNA levels than the other treatments (P < 0.05) ( Figures 7A and 7C) . Pretreatment with c9, t11-CLA increased the mRNA level of SOD1 compared with the H 2 O 2 group (P < 0.05). Interestingly, no remarkable differences (P > 0.05) in the Mn superoxide dismutase (SOD2) mRNA levels were observed among all the treatments ( Figure 7B ).
No significant difference (P > 0.05) in the Nrf2 mRNA levels was observed in the hepatocytes ex- Figure 5 . The effect of c9, t11-CLA and t10, c12-CLA on intracellular MDA levels in hepatocytes. Hepatocytes were treated with 100 μmol/L c9, t11-CLA; t10, c12-CLA; or LA for 24 h. The cultures were then washed twice, and 4 mmol/L H 2 O 2 was added for another 2 h to all cultures except for the control group. The intracellular MDA levels were measured using a spectrophotometric method. The data for 1 representative experiment from 3 independent experiments are expressed as the mean ± SEM (n = 3). Means without a common letter differ (P < 0.05).
posed to H 2 O 2 compared with the control. The hepatocytes pretreated with t10, c12-CLA or LA, but not c9, t11-CLA, exhibited markedly increased (P < 0.05) Nrf2 mRNA levels compared with the H 2 O 2 group. Nrf2 mRNA expression in the t10, c12-CLA group was highest (P < 0.05) among all treatment groups (Figure 8) .
Compared with the H 2 O 2 group, pretreatment with t10, c12-CLA, but not pretreatment with c9, t11-CLA, decreased (P < 0.05) Nrf2 protein expression in the cytoplasm; in the nucleus, pretreatment with t10, c12-CLA enhanced Nrf2 protein expression compared with the H 2 O 2 group (P < 0.05). The above results indicate that t10, c12-CLA promotes Nrf2 nuclear translocation (Figure 9 ). Figure 6 . The effect of c9, t11-CLA and t10, c12-CLA on SOD (A) and CAT (B) activities in hepatocytes. Hepatocytes were treated with 100 μmol/L c9, t11-CLA; t10, c12-CLA; or LA for 24 h. The cultures were then washed twice, and 4 mmol/L H 2 O 2 was added for another 2 h to all cultures except for the control group. The activities of antioxidant enzymes were measured using a spectrophotometric method. The data for 1 representative experiment from 3 independent experiments are expressed as the mean ± SEM (n = 3). Means without a common letter differ (P < 0.05). The effect of c9, t11-CLA and t10, c12-CLA on mRNA expression of SOD1 (A), SOD2 (B) and CAT (C). Hepatocytes were treated with 100 μmol/L c9, t11-CLA; t10, c12-CLA; or LA for 24 h. The cultures were then washed twice, and 4 mmol/L H 2 O 2 was added for another 2 h to all cultures except for the control group. Gene expression in hepatocytes was measured through quantitative real-time RT-PCR. The data for 1 representative experiment from 3 independent experiments are expressed as the mean ± SEM (n = 3). Means without a common letter differ (P < 0.05).
DISCUSSION
In laying hens, hepatic lipogenesis is dramatically enhanced by estrogens to meet the high demand for egg production (Qi et al., 2011) . The liver is highly involved in oxidative metabolism. Thus, we used primary lay- Figure 8 . The effect of c9, t11-CLA and t10, c12-CLA on Nrf2 mRNA expression. Hepatocytes were treated with 100 μmol/L c9, t11-CLA; t10, c12-CLA; or LA for 24 h. The cultures were then washed twice, and 4 mmol/L H 2 O 2 was added for another 2 h to all cultures except for the control group. Gene expression in hepatocytes was measured through quantitative real-time RT-PCR. The data for 1 representative experiment from 3 independent experiments were expressed as the mean ± SEM (n = 3). Means without a common letter differ (P < 0.05).
ing hen hepatocytes to investigate whether CLA is an antioxidant, which isomer (c9, t11 or t10, c12-CLA) plays a major role in this process, and its antioxidant mechanism. H 2 O 2 is widely used as an inducer of oxidative stress (Li et al., 2010) . Here we induced oxidative stress in primary laying hen hepatocytes using H 2 O 2 to specifically investigate the antioxidant capacity of CLAs. In the current study, pretreatment with either c9, t11-CLA or t10, c12-CLA clearly protected the hepatocytes against H 2 O 2 -induced cytotoxicity. ROS production in H 2 O 2 treatment group was higher than that in control group, which was obviously suppressed by pretreating the cells with t10, c12-CLA, but not with c9, t11-CLA or LA. A similar result was observed by Leung and Liu (2000) wherein the t10, c12-CLA isomer exhibited a greater oxyradical scavenging capacity than the c9, t11-CLA isomer; which might be why t10, c12-CLA can improve hepatocyte cell viability relative to the H 2 O 2 group.
Malondialdehyde is a major oxidation product of peroxidized polyunsaturated fatty acids and an important indicator of lipid peroxidation (Freeman and Crapo, 1981) . In this study, we found that the MDA levels increased upon insult with H 2 O 2 compared with the control. Compared with the H 2 O 2 treatment, pretreatment with c9, t11-CLA, t10, c12-CLA or LA did not increase the MDA levels. In contrast, the MDA production in group c9, t11-CLA and t10, c12-CLA decreased by 2.7% and 2.1% respectively compared with the H 2 O 2 group. It has been reported that CLA was the only PUFA that protected human fibroblasts against peroxidative damage without MDA or ROS overproduction. The particular hairpin conformation generated for CLA through molecular modelling may account for this specific biological effect (Arab et al., 2006 ). Superoxide dismutase and CAT are major intracellular antioxidant defenses and can scavenge ROS as well as play an important role in protecting cells against oxidative stress-induced injury. In the current study, we found that pretreatment with t10, c12-CLA, but not c9, t11-CLA or LA, significantly increased the activities of both enzymes compared with the H 2 O 2 group, which indicates that t10, c12-CLA has more potential for improving the antioxidant capacity. Compared with the H 2 O 2 group, t10, c12-CLA induced activity in the antioxidant enzymes SOD and CAT, enhanced free radical scavenging in hepatocytes, and reduced intracellular ROS production without MDA overproduction. These results indicate that t10, c12-CLA does not completely depend on its direct reaction with oxygen radicals to scavenge free radicals. We speculate that t10, c12-CLA may reduce ROS by increasing antioxidant enzyme activity, thereby protecting cells against H 2 O 2 injury.
The activity of an antioxidant enzyme is closely related to its gene expression. The mRNA levels affect the antioxidant enzyme activities, which may be enhanced through increasing gene expression for antioxidant enzymes (Tiedge et al., 1997 ). In the current study, we attempted to determine the effects of CLA isomers on antioxidant enzyme mRNA levels and to correlate the modulations in transcript levels with modulations in enzyme activity. Our results clearly show higher SOD1 and CAT mRNA levels after pretreating hepatocytes with 100 μmol/L t10, c12-CLA for 24 h than with other treatments. Although c9, t11-CLA and LA also increased SOD1 and CAT gene expression, the increase was significantly lower than in the t10, c12-CLA group. Interestingly, we did not observe remarkable differences in the SOD2 mRNA levels among the treatments. The antioxidant enzyme SOD2 may not play a primary role in preventing H 2 O 2 injury in hepatocytes. Notably, the variation between gene expression and enzyme activity in antioxidant enzymes was almost the same in the t10, c12-CLA group. These data suggest that increases in intracellular SOD and CAT activities after pretreatment with 100 μmol/L t10, c12-CLA are largely controlled at the mRNA level. We confirm, at least in part, that t10, c12-CLA enhanced the antioxidant enzyme activities by up-regulating the gene expression and increasing the enzyme levels. However, this result is contradictory to the report by Rybicka et al. (2011) wherein c9, t11-CLA, but not t10, c12-CLA, significantly increased CAT activity. Both isomers significantly decreased CAT mRNA expression, and adverse metabolic effects were observed from each isomer's activity (Rybicka et al., 2011) , which may be related to the following 3 factors. (1) Different experimental subjects may cause different results.
(2) Different CLA isomer concentrations may cause different effects on the antioxidant defense system. CLA isomers may be less susceptible to oxidation at high concentrations (100 μmol/L) and act as activators to induce expression of antioxidant enzymes (Nakamura and Omaye, 2009) . (3) The design of the current experiment differed from other studies on CLA antioxidant capacity. In other study, cells are typically directly treated with CLA and then analyzed in comparison with a control group (Rybicka et al., 2011) . However, in our experimental design, we stimulated the cells with H 2 O 2 to induce oxidative injury in hepatocytes and further study the antioxidant capacities of CLA isomers based on the oxidative injury, focusing only on the antioxidative effects.
Nrf2 is a member of the Cap "n" Collar family of basic region-leucine zipper (bZIP) transcription factors and is a key transcription factor that regulates the antioxidant response (Li and Kong, 2009) . To confirm that the Nrf2 is involved in CLA-induced antioxidant enzyme activation, the effects of CLA isomers on Nrf2 mRNA and protein expression were determined. Our results show that t10, c12-CLA, but not c9, t11-CLA, markedly increased the level of Nrf2 mRNA compared with the H 2 O 2 group, which indicates that t10, c12-CLA plays a major role in stimulating Nrf2 mRNA expression. Next, Nrf2 protein expression was evaluated using Western blotting. The results show that t10, c12-CLA decreased Nrf2 protein expression in the cytoplasm and increased Nrf2 protein expression in the nucleus, which suggests that t10, c12-CLA promotes Nrf2 nuclear translocation and further supports involvement of the Nrf2/ARE mechanism in CLA-mediated antioxidant enzyme activation. These results demonstrate a higher protective effect by t10, c12-CLA against H 2 O 2 -mediated oxidative injury, at least in part, through its ability to activate the nuclear translocation of Nrf2 and enhance downstream gene expression of antioxidant enzymes. However, a more recent study shows a contradictory result, wherein dietary supplementation of c9, t11-CLA in young rats activated Nrf2-mediated cytoprotective defenses against oxidative stress more efficiently than t10, c12-CLA (Mollica et al., 2014) . The explanation for this discrepancy can be attributed to a different experimental design or different animal models used. Altogether, the above results suggest that t10, c12-CLA may act as a Nrf2 activator to promote Nrf2 nuclear translocation, which induces mRNA expression of antioxidant enzymes, enhances antioxidant enzyme activities, reduces ROS generation, and, finally, protects hepatocytes from oxidative damage induced by H 2 O 2 .
In summary, the present study demonstrated that t10, c12-CLA exhibited a stronger antioxidant capacity than c9, t11-CLA in primary cultured laying hen hepatocytes. t10, c12-CLA could mitigate damage in hepatocytes caused by ROS via enhancing the defense capability of the antioxidant enzyme system. Furthermore, t10, c12-CLA increased the activity and mRNA expression of antioxidant enzymes via facilitating nuclear translocation of Nrf2. More research to elucidate the mechanisms by which t10, c12-CLA enhances nuclear translocation of Nrf2 is warranted.
